Call me harsh, but I told my mother, “Grandmother has never written me a thank you note, and I gave her a gift. I will start writing when she does!” I read these complaints in your column and ...

Invitations to attend special faculty meetings and events. Inclusion of the Dalhousie Adjunct Clinical Associate appointment on their résumé. Physiotherapists who meet the eligibility criteria are ...

Therefore, clinical ... Inclusion criteria for this study were as follows: (1) case reports documenting Atezolizumab-induced encephalitis, aseptic meningitis, or meningoencephalitis; (2) full articles ...

The Food and Drug Administration has removed webpages about diversity and inclusion in clinical trials for cancer drugs. The page for Project Equity, a 2021 initiative launched by the FDA's ...

We are grateful for the thoughtful commentaries to our article on patient selection for first clinical trials ... not serve as hard exclusion criterion but rather as a positive inclusion criterion, ...

and inclusion has ensnared many pages focused on ensuring that clinical trials used to test drugs and medical devices include people of different ethnic and economic backgrounds. The purging of ...

Investigators find that most exclusion criteria in critical care randomized clinical ... Center for the Study of Drug Development recently published by Applied Clinical Trials notes that recent FDA ...

Further research is needed to clarify their ... China. After rigorous inclusion and exclusion criteria, 6,943 patients receiving azvudine and 1,202 receiving Paxlovid were eligible for analysis.

The new paper, published January 7 in Notes and Records: The Royal Society Journal of the History of Science, sheds light on early clinical trials that pushed for a more critical, open-minded ...

In this trial, 119 patients with ... were nonresponders under the 5 mm RANO-BM criteria (n = 14) had OS outcomes comparable to those categorized as responders under RANO-BM 5 mm (n = 41). It was ...

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer. Two new studies led by ...